The invention discloses a method for preparing myricetin/HP-beta-CD inclusion compound superfine granules through a supercritical CO2 anti-solvent technique. The method comprises the following steps of (1) compounding a myricetin-carrier mixed solution: weighing myricetin raw material medicines and a water-soluble carrier namely hydroxypropyl-beta-cyclodextrin, and enabling the weighed myricetin raw material medicines and the weighed water-soluble carrier namely hydroxypropyl-beta-cyclodextrin to dissolve in an organic solvent to obtain the myricetin-carrier mixed solution, wherein the organicsolvent is ethanol, and the molar ratio of the raw material medicines to the carrier is 1 to 1; (2) charging CO2 into a crystallization kettle at a certain flow rate, and regulating temperature and pressure in the crystallization kettle; (3) continuing charging the CO2, maintaining the temperature and the pressure in the crystallization kettle unchanged, and at the same time, spraying the myricetin-carrier mixed solution prepared in the step (1) into the crystallization kettle from the top of the crystallization kettle through a nozzle by a high-pressure liquid delivery pump; and (4) after completion of sample introduction, continuing charging the CO2 for some time, completely discharging remaining solvents, releasing pressure, opening the crystallization kettle, and collecting products.The myricetin/HP-beta-CD inclusion compound superfine granules obtained by the method can notably improve dissolving-out properties, and improvement of the biological availability of the myricetin isfacilitated.